1-3 of 3
Sherry Adkins
Close
Sort by
Journal Articles

A phase 1 study of prophylactic anakinra to mitigate ICANS in patients with large B-cell lymphoma

Clinical Trials & Observations
Paolo Strati, Andrew Jallouk, Qing Deng, Xubin Li, Lei Feng, Ryan Sun, Sherry Adkins, Swapna Johncy, Taylor Cain, Raphael E. Steiner, Sairah Ahmed, Dai Chihara, Luis E. Fayad, Swaminathan P. Iyer, Sandra Horowitz, Loretta J. Nastoupil, Ranjit Nair, Ahmed Hassan, Taher E. Daoud, Misha Hawkins, Maria A. Rodriguez, Elizabeth J. Shpall, Jeremy L. Ramdial, Partow Kebriaei, David S. Hong, Jason R. Westin, Sattva S. Neelapu, Michael R. Green
Journal: Blood Advances
Blood Adv (2023) 7 (21): 6785–6789.
https://doi.org/10.1182/bloodadvances.2023010653
Published: 2023
Includes: Supplemental data
Journal Articles

Clinical and radiologic correlates of neurotoxicity after axicabtagene ciloleucel in large B-cell lymphoma

Clinical Trials & Observations
Paolo Strati, Loretta J. Nastoupil, Jason Westin, Luis E. Fayad, Sairah Ahmed, Nathan H. Fowler, Fredrick B. Hagemeister, Hun J. Lee, Swaminathan P. Iyer, Ranjit Nair, Simrit Parmar, Maria A. Rodriguez, Felipe Samaniego, Raphael E. Steiner, Michael Wang, Chelsea C. Pinnix, Sherry Adkins, Catherine M. Claussen, Charles S. Martinez, Misha C. Hawkins, Nicole A. Johnson, Prachee Singh, Haleigh E. Mistry, Sandra Horowitz, Shirley George, Lei Feng, Partow Kebriaei, Elizabeth J. Shpall, Sattva S. Neelapu, Sudhakar Tummala, T. Linda Chi
Journal: Blood Advances
Blood Adv (2020) 4 (16): 3943–3951.
https://doi.org/10.1182/bloodadvances.2020002228
Published: 2020
Journal Articles

Bridging therapy prior to axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma

Clinical Trials & Observations
Chelsea C. Pinnix, Jillian R. Gunther, Bouthaina S. Dabaja, Paolo Strati, Penny Fang, Misha C. Hawkins, Sherry Adkins, Jason Westin, Sairah Ahmed, Luis Fayad, Hun Ju Lee, Ranjit Nair, Raphael E. Steiner, Swaminathan P. Iyer, M. Alma Rodriguez, Michael Wang, Christopher Flowers, Sattva S. Neelapu, Loretta J. Nastoupil
Journal: Blood Advances
Blood Adv (2020) 4 (13): 2871–2883.
https://doi.org/10.1182/bloodadvances.2020001837
Published: 2020